AzTrials
AzTrials

Self-Harm, DeliberateNCT04962373

Brief Admission for Adolescents Who Self-harm

An observational study of Self-Harm, Deliberate and Suicide, Attempted, run by Region Skane at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is still no consensus on how to manage suicidal behavior in youth with recurrent self-harm at times when the risk for suicide is imminent (1). Brief Admission (BA) has evolved as a promising crisis intervention for adults with self-harm (2). Read more about this study

Who is it for?
Ages 13 to 100 years
What is being tested?
Semi-structured interviews
How many people
59 participants
Where
1 siteSweden
Study dates
1 Sep 2020to 30 Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 100 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Adolescents with an active BA contract, their loved ones who have given informed consent to participate and psychiatric staff working with the adolescents.

Who may be able to join

  • Adolescents with an active BA contract
  • At least 13 years of age.
  • Able to consent to study participation through written and oral information.
  • Consent from caregivers
  • Given consent to participate
  • Parents to adolescents with an active BA contract
Show all 13Show fewer
  • At least 18 years of age.
  • Able to consent to study participation through written and oral information.
  • Given consent to participate
  • Staff working with adolescents with an active BA contract
  • At least 18 years of age.
  • Able to consent to study participation through written and oral information.
  • Given consent to participate

Who cannot join

  • Below the age of 13.
  • Sample 2:
  • None
  • Sample 3:
  • None

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Psykiatri och habilitering, Region Skåne

    Lund, Skåne County, 22185

Other trials in Sweden

About this study

Official title: Brief Admission by Self-referral for Adolescents Who Self-harm, at Risk for Suicide. A Qualitative Study to Optimise and Standardise the Intervention

There is still no consensus on how to manage suicidal behavior in youth with recurrent self-harm at times when the risk for suicide is imminent (1). Brief Admission (BA) has evolved as a promising crisis intervention for adults with self-harm (2). The characteristics of BA is different from other types of admission, being focused on prevention through increased autonomy and self-care, based on structured and voluntary brief self-referrals to hospital (3). As a result of a randomized controlled trial, BA is since January 2019, continuously offered to adults with self-harm at risk for suicide in Skåne (4). Parallel to this clinical trial, the method has been adapted to work in a psychiatric setting for adolescents. At present 24 adolescents have access to the method in Skåne. Clinical experiences from staff are promising, however, the lived experiences have not been collected in a standardized way.

The aim of the present study is to gather information on how BA in its present, standardized form works for adolescents, their loved ones and staff working at the ward providing BA. This will be done through semi-structured interviews with:

  1. Adolescents using BA and their loved ones
  2. Staff working at the ward providing BA. Data will be analyzed with qualitative analysis (5, 6). The ultimate aim is to use these results to optimize the current standardized version of BA for adolescents in order to test in a randomized clinical trial.
Being tested
Semi-structured interviews
Medical subject headings
Self-Injurious Behavior, Suicide, Attempted

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Semi-structured interviewsOther

    Each participant will attend a 30-60 minute semi-structured interview conducted by the CI

Study groups in NCT04962373
Study groupRoleWhat they receive
AdolescentsAdolescents with a contract for Brief admission by self-referral
Receives: Other: Semi-structured interviews
ParentsParents to adolescents with a contract for Brief admission by self-referral
Receives: Other: Semi-structured interviews
StaffHealth care providers who work with adolescents with a contract for Brief admission by self-referral
Receives: Other: Semi-structured interviews

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived effective components of Brief Admission for adolescents

    Qualitative data from interviews

    Measured: 60mins

  2. Potential adaptations of the method to better fit adolescents

    Qualitative data from interviews

    Measured: 60mins

  3. Areas where Brief Admission have the most prominent perceived effects in adolescents

    Qualitative data from interviews

    Measured: 60mins

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2021
  2. Study start1 Sep 2020
  3. Primary completion30 Jun 2025
  4. Study completion30 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
59 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04962373
Sponsor's protocol ID
2020-01840
Status last verified
Aug 2025
First submitted
4 Jul 2021
Last updated
6 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data is qualitative, transcriptions from interviews. Even if personal identifiers are removed, it is difficult to ensure enough secrecy/privacy for the participants.

Publications

  • Strand M, von Hausswolff-Juhlin Y. Patient-controlled hospital admission in psychiatry: A systematic review. Nord J Psychiatry. 2015;69(8):574-86. doi: 10.3109/08039488.2015.1025835. Epub 2015 Apr 2.

    PubMed 25832757
  • Westling S, Daukantaite D, Liljedahl SI, Oh Y, Westrin A, Flyckt L, Helleman M. Effect of Brief Admission to Hospital by Self-referral for Individuals Who Self-harm and Are at Risk of Suicide: A Randomized Clinical Trial. JAMA Netw Open. 2019 Jun 5;2(6):e195463. doi: 10.1001/jamanetworkopen.2019.5463.

    PubMed 31173128
  • Lindseth A, Norberg A. A phenomenological hermeneutical method for researching lived experience. Scand J Caring Sci. 2004 Jun;18(2):145-53. doi: 10.1111/j.1471-6712.2004.00258.x.

    PubMed 15147477
  • Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004 Feb;24(2):105-12. doi: 10.1016/j.nedt.2003.10.001.

    PubMed 14769454
  • Helleman M, Lundh LG, Liljedahl SI, Daukantaite D, Westling S. Individuals' experiences with brief admission during the implementation of the brief admission skane RCT, a qualitative study. Nord J Psychiatry. 2018 Jul;72(5):380-386. doi: 10.1080/08039488.2018.1467966. Epub 2018 Apr 27.

    PubMed 29703119
  • Lindkvist RM, Landgren K, Liljedahl SI, Daukantaite D, Helleman M, Westling S. Predictable, Collaborative and Safe: Healthcare Provider Experiences of Introducing Brief Admissions by Self-referral for Self-harming and Suicidal Persons with a History of Extensive Psychiatric Inpatient Care. Issues Ment Health Nurs. 2019 Jul;40(7):548-556. doi: 10.1080/01612840.2019.1585497. Epub 2019 May 17.

    PubMed 31099707
  • Lindkvist RM, Westling S, Liljedahl SI, Landgren K. A Brief Breathing Space: Experiences of Brief Admission by Self-Referral for Self-Harming and Suicidal Individuals with a History of Extensive Psychiatric Inpatient Care. Issues Ment Health Nurs. 2021 Feb;42(2):172-182. doi: 10.1080/01612840.2020.1789787. Epub 2020 Aug 7.

    PubMed 32762578

Questions about this trial

What is this clinical trial studying?

An observational study of Self-Harm, Deliberate and Suicide, Attempted, run by Region Skane at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived effective components of Brief Admission for adolescents (time frame: 60mins). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04962373, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in